|
|
6/25/2007
|
Consumers Union called on hospitals today to take more aggressive steps to protect patients from Methicillin-resistant Staphylococcus aureus (MRSA) infections in light of a new study showing that the superbug is much more common in hospitals than previous estimates had indicated. |
|
|
5/3/2006
|
Over the last five years, the federal Food and Drug Administration (FDA) sent prescription drug companies 170 enforcement letters criticizing “false” or “misleading” advertising that omitted or minimized risks, promoted unproven uses, and made other deceptive claims to both doctors and consumers. Those letters addressed the marketing of 150 different drugs, including Vioxx, Paxil, Oxycontin and Accutane, according to a new report released today by the MASSPIRG Education Fund. |
|
|
10/21/2004
|
BOSTON—Uninsured consumers in Massachusetts are charged on average, more than twice as much—117 percent more—for drugs purchased at their local pharmacy than they would pay if they purchased the same drugs from a Canadian pharmacy, and 89 percent more than the federal government pays according to a survey released today by the Massachusetts Public Interest Research Group, (MASSPIRG). |
|
|
09/28/2004
|
BOSTON—Consumer, health care, and senior groups working to lower the price of prescription drugs challenged the findings of the recently released report on the drug industry by the Beacon Hill Institute. |
|
|
09/27/2007
|
Sept. 27, 2007. President Bush today signed the comprehensive Food and Drug Administration bill that focuses on prescription drug safety reforms. The bill holds the prescription drug industry more accountable for the safety of their products by requiring them to publicly disclose drug safety studies, even the ones that show their medicines in an unflattering light. It also increases the budget for drug safety reviews at the Food and Drug Administration. |
|
|
09-19-2007
|
The House today passed significant reforms to the Food and Drug Administration’s drug safety review system. Part of a comprehensive FDA bill, the bill was a compromise between Senate and House legislation that passed overwhelmingly earlier this year. The bill, which includes strong consumer protections, will be voted on in the Senate tomorrow. |
|
|
04/21/2008
|
(Boston) MASSPIRG praised the action of the Massachusetts Senate on Thursday April 17, who adopted much needed prescription drug marketing reforms as part of the Senate President’s Health Care Cost Control Bill, S. 2650, An Act to Promote Cost Containment, Transparency and Efficiency in the Delivery of Quality Health Care. |
|
|
03/03/2008
|
Coalition applauds Senate President Murray for including provisions aimed at reining in excessive prescription drug prices in the cost control legislation that she introduced today. The legislation includes a ban on gifts from pharmaceutical companies to prescribers and proposes an evidence-based physician education program (often referred to as “academic detailing”). |
|
|
01/17/2008
|
At a State House news conference, MASSPIRG joined The Massachusetts Prescription Reform Coalition in launching an effort to lower health care costs through reforming the prescription drug industry. |
